Dallah Healthcare Co. posted a net profit of SAR 94.7 million in Q1 2023, a 15% increase from SAR 82.6 million a year earlier.
| Item | Q1 2022 | Q1 2023 | Change |
|---|---|---|---|
| Revenues | 609.40 | 716.64 | 17.6 % |
| Gross Income | 231.69 | 266.79 | 15.1 % |
| Operating Income | 109.93 | 138.08 | 25.6 % |
| Net Income | 82.63 | 94.66 | 14.6 % |
| Average Shares | 90.00 | 97.68 | 8.5 % |
| EPS (Riyals) | 0.92 | 0.97 | 5.6 % |
| Item | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Revenues | 693.88 | 716.64 | 3.3 % |
| Gross Income | 239.81 | 266.79 | 11.3 % |
| Operating Income | 101.69 | 138.08 | 35.8 % |
| Net Income | 78.44 | 94.66 | 20.7 % |
| Average Shares | 90.00 | 97.68 | 8.5 % |
| EPS (Riyals) | 0.87 | 0.97 | 11.2 % |
The positive performance was driven by an 18% year-on-year (YoY) increase in revenue to SAR 717 million due to higher number of inpatients and outpatients and higher occupancy rates.
Dallah’s loss share in investee companies decreased by SAR 8 million to SAR 2 million due to the improved performance of the investee companies.
This was partially offset by the increase in financing expenses, which reached SAR 28 million for the first quarter of 2023, compared to SAR 11 million for the same quarter in 2022.
Sequentially, net profit rose 20.7% from SAR 78.4 million in Q4 2022.
Shareholders’ equity, excluding minority interest, stood at SAR 3.12 billion as of March 31, 2023, compared to SAR 1.95 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}